Inventor · disambiguated record
Said M. Sebti
Also filed as: SEBTI SAID · SEBTI SAID M
109 granted patents·24 pending applications·554 citations·filing 1993–2024
99Inventor score
Files withUNIV SOUTH FLORIDA41H LEE MOFFITT CANCER CT & RES36CHENG JIN Q14SEBTI SAID M12UNIV PITTSBURGH11
Top patents by PatentIndex Score
133 records- 0197US5602098AInhibition of farnesyltransferaseUNIV PITTSBURGH·Filed 1993·Granted Feb 11, 1997·136 cites·10 claims
- 0291US8183249B2Inhibitors of AKT/PKB with anti-tumor activityCHENG JIN Q·Filed 2008·Granted May 22, 2012·8 cites·16 claims
- 0390US7977381B2Platinum complexes and methods for inhibiting tumor cell proliferationUNIV SOUTH FLORIDA·Filed 2007·Granted Jul 12, 2011·8 cites·20 claims
- 0489US8642278B2Inhibition of cell proliferationSEBTI SAID M·Filed 2006·Granted Feb 4, 2014·7 cites·86 claims
- 0589US8466157B2Proteasome inhibitors having chymotrypsin-like activityLAWRENCE HARSHANI·Filed 2011·Granted Jun 18, 2013·9 cites·18 claims
- 0689US8435959B2Effective treatment of tumors and cancer with triciribine and related compoundsCHENG JIN Q·Filed 2005·Granted May 7, 2013·12 cites·18 claims
- 0788US7960434B2Small molecule inhibitors of STAT3 with anti-tumor activityUNIV SOUTH FLORIDA·Filed 2007·Granted Jun 14, 2011·10 cites·16 claims
- 0887US9597329B2Aurora kinase inhibitors and methods of making and using thereofSEBTI SAID M·Filed 2016·Granted Mar 21, 2017·4 cites·12 claims
- 0987US5849790A(Mono) ethylenediaminenitroplatinum (IV) complexes with ligands of oxides of nitrogen as possible anti-tumor agentsUNIV SOUTH FLORIDA·Filed 1996·Granted Dec 15, 1998·45 cites·12 claims
- 1086US8455543B2Platinum complexes and methods for inhibiting tumor cell proliferationKAY HEIDI·Filed 2011·Granted Jun 4, 2013·4 cites·1 claims
- 1184US7713960B2Inhibition of the Raf/Mek/P-Erk pathway for treating cancerUNIV SOUTH FLORIDA·Filed 2006·Granted May 11, 2010·8 cites·5 claims
- 1284US6310095B1Inhibitors of protein isoprenyl transferasesUNIV PITTSBURGH·Filed 1998·Granted Oct 30, 2001·39 cites·14 claims
- 1383US8691799B2Materials and methods for treatment of cancer and identification of anti-cancer compoundsSEBTI SAID M·Filed 2011·Granted Apr 8, 2014·2 cites·19 claims
- 1482US8901086B2Compositions including triciribine and methods of use thereofCHENG JIN Q·Filed 2012·Granted Dec 2, 2014·2 cites·18 claims
- 1582US2023201191A1Platinum compounds that inhibit constitutive stat3 signaling and induce cell cycle arrest and apoptosis of malignant cellsH LEE MOFFITT CANCER CT & RES·Filed 2023·Application pending·0 cites
- 1681US6221865B1Inhibitors of protein isoprenyl transferasesUNIV PITTSBURGH·Filed 1998·Granted Apr 24, 2001·30 cites·15 claims
- 1781US6011175AInhibition of farnesyltransferaseUNIV PITTSBURGH·Filed 1996·Granted Jan 4, 2000·23 cites·21 claims
- 1880US10376495B2Small molecules that mimic or antagonize actions of granulocyte colony-stimulating-factor (G-CSF)UNIV SOUTH FLORIDA·Filed 2017·Granted Aug 13, 2019·1 cites·12 claims
- 1980US9968599B2Platinum compounds that inhibit constitutive STAT3 signaling and induce cell cycle arrest and apoptosis of malignant cellsH LEE MOFFITT CANCER CT & RES·Filed 2015·Granted May 15, 2018·1 cites·18 claims
- 2080US8846653B2Delta-tocotrienol treatment and prevention of pancreatic cancerUNIV SOUTH FLORIDA·Filed 2012·Granted Sep 30, 2014·2 cites·14 claims
- 2180US8623834B2Compositions including triciribine and trastuzumab and methods of use thereofCHENG JIN Q·Filed 2012·Granted Jan 7, 2014·2 cites·17 claims
- 2280US2024368089A1Aurora kinase and janus kinase inhibitors for prevention of graft versus host diseaseH LEE MOFFITT CANCER CT & RES·Filed 2024·Application pending·0 cites
- 2379US6204293B1Inhibitors of protein isoprenyl transferasesUNIV PITTSBURGH·Filed 1998·Granted Mar 20, 2001·26 cites·15 claims
- 2479US5965539AInhibitors of prenyl transferasesUNIVERISTY OF PITTSBURGH·Filed 1996·Granted Oct 12, 1999·41 cites·26 claims
- 2578US12060332B2Aurora kinase and janus kinase inhibitors for prevention of graft versus host diseaseH LEE MOFFITT CANCER CT & RES·Filed 2023·Granted Aug 13, 2024·0 cites·3 claims
- 2678US9040563B2Dual inhibitors of farnesyltransferase and geranylgeranyltransferase IH LEE MOFFITT CANCER CT & RES·Filed 2013·Granted May 26, 2015·2 cites·14 claims
- 2778US7632805B2Growth factor binding moleculesUNIV SOUTH FLORIDA·Filed 2005·Granted Dec 15, 2009·2 cites·37 claims
- 2878US7157419B2Growth factor binding moleculesUNIV SOUTH FLORIDA·Filed 2001·Granted Jan 2, 2007·3 cites·6 claims
- 2977US10358454B2Marinopyrrole derivatives and methods of making and using sameH LEE MOFFITT CANCER CT & RES·Filed 2018·Granted Jul 23, 2019·1 cites·12 claims
- 3077US9868747B2Marinopyrrole derivatives and methods of making and using sameH LEE MOFFITT CANCER CT & RES·Filed 2015·Granted Jan 16, 2018·1 cites·20 claims
- 3177US9498492B2Compositions including triciribine and taxanes and methods of use thereofUNIV SOUTH FLORIDA·Filed 2015·Granted Nov 22, 2016·1 cites·14 claims
- 3277US9115162B2Effective treatment of tumors and cancer with triciribine and related compoundsUNIV SOUTH FLORIDA·Filed 2013·Granted Aug 25, 2015·2 cites·17 claims
- 3376US10954258B2STAT3 dimerization inhibitorsH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Mar 23, 2021·0 cites·16 claims
- 3476US9453049B2Substrate-mimetic Akt inhibitorSEBTI SAID M·Filed 2014·Granted Sep 27, 2016·1 cites·13 claims
- 3576US8828451B2Akt sensitization of cancer cellsSEBTI SAID M·Filed 2007·Granted Sep 9, 2014·2 cites·5 claims
- 3676US8822524B2Substrate-mimetic Akt inhibitorSEBTI SAID M·Filed 2009·Granted Sep 2, 2014·1 cites·5 claims
- 3776US8609639B2Stat3 inhibitor having anti-cancer activity and methodsTURKSON JAMES·Filed 2007·Granted Dec 17, 2013·2 cites·21 claims
- 3875US11571418B2Platinum compounds that inhibit constitutive STAT3 signaling and induce cell cycle arrest and apoptosis of malignant cellsH LEE MOFFITT CANCER CT & RES·Filed 2020·Granted Feb 7, 2023·0 cites·18 claims
- 3975US7951924B2RhoB variants and methods of useUNIV SOUTH FLORIDA·Filed 2005·Granted May 31, 2011·1 cites·24 claims
- 4075US6693123B2Inhibitors of protein isoprenyl transferasesUNIV PITTSBURGH·Filed 2001·Granted Feb 17, 2004·7 cites·7 claims
- 4175US2011008327A1Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereofCHENG JIN Q·Filed 2008·Application pending·0 cites
- 4274US10806712B2Small molecule inhibitors of STAT3 with anti-tumor activityH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Oct 20, 2020·0 cites·6 claims
- 4374US10711014B2Mutant KRas inhibitorsH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Jul 14, 2020·0 cites·7 claims
- 4474US2010009929A1Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereofCHENG JIN Q·Filed 2008·Application pending·0 cites
- 4574US2021121427A1Small molecule inhibitors of stat3 with anti-tumor activityH LEE MOFFITT CANCER CT & RES·Filed 2020·Application pending·0 cites
- 4674US2010009928A1Compositions including triciribine and taxanes and methods of use thereofCHENG JIN Q·Filed 2008·Application pending·0 cites
- 4773US10813927B2Platinum compounds that inhibit constitutive STAT3 signaling and induce cell cycle arrest and apoptosis of malignant cellsH LEE MOFFITT CANCER CT & RES·Filed 2018·Granted Oct 27, 2020·0 cites·15 claims
- 4873US9221808B2Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinase (ROCK) and methods of useLAWRENCE NICHOLAS J·Filed 2011·Granted Dec 29, 2015·4 cites·12 claims
- 4973US8623906B2Carboxy isatin hydrazones and their esters as Shp2 inhibitorsWU JIE·Filed 2011·Granted Jan 7, 2014·1 cites·5 claims
- 5072US11352370B2Mutant KRAS inhibitorsH LEE MOFFITT CANCER CT & RES·Filed 2020·Granted Jun 7, 2022·0 cites·15 claims
Showing the top 50 of 133 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →